Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;2(1):46-53.
doi: 10.1177/2396987316679577. Epub 2016 Nov 15.

Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation)

Kateryna Antonenko  1 Maurizio Paciaroni  2 Giancarlo Agnelli  2 Nicola Falocci  2 Cecilia Becattini  2 Simona Marcheselli  3 Christina Rueckert  4 Alessandro Pezzini  5 Loris Poli  5 Alessandro Padovani  5 Laszló Csiba  6 Lilla Szabó  6 Sung-Il Sohn  7 Tiziana Tassinari  8 Azmil H Abdul-Rahim  9 Patrik Michel  10 Maria Cordier  10 Peter Vanacker  11 Suzette Remillard  10 Andrea Alberti  2 Michele Venti  2 Monica Acciarresi  2 Cataldo D'Amore  2 Umberto Scoditti  12 Licia Denti  13 Giovanni Orlandi  14 Alberto Chiti  14 Gino Gialdini  14 Paolo Bovi  15 Monica Carletti  15 Alberto Rigatelli  15 Jukka Putaala  16 Turgut Tatlisumak  16   17   18 Luca Masotti  19 Gianni Lorenzini  19 Rossana Tassi  20 Francesca Guideri  20 Giuseppe Martini  20 Georgios Tsivgoulis  21   22   23 Kostantinos Vadikolias  21 Sokratis G Papageorgiou  23 Francesco Corea  24 Massimo Del Sette  25 Walter Ageno  26 Maria Luisa De Lodovici  27 Giorgio Bono  27 Antonio Baldi  28 Sebastiano D'Anna  28 Simona Sacco  29 Antonio Carolei  29 Cindy Tiseo  29 Davide Imberti  30 Dorjan Zabzuni  30 Boris Doronin  31 Vera Volodina  31 Domenico Consoli  32 Franco Galati  32 Alessio Pieroni  33 Danilo Toni  33 Serena Monaco  34 Mario M Baronello  34 Kristian Barlinn  35 Lars-Peder Pallesen  35 Jessica Kepplinger  35 Ulf Bodechtel  35 Johannes Gerber  35 Dirk Deleu  36 Gayane Melikyan  36 Faisal Ibrahim  36 Naveed Akhtar  36 Maria G Mosconi  2 Kennedy R Lees  9 Valeria Caso  2
Affiliations

Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation)

Kateryna Antonenko et al. Eur Stroke J. 2017 Mar.

Abstract

Introduction: Atrial fibrillation is an independent risk factor of thromboembolism. Women with atrial fibrillation are at a higher overall risk for stroke compared to men with atrial fibrillation. The aim of this study was to evaluate for sex differences in patients with acute stroke and atrial fibrillation, regarding risk factors, treatments received and outcomes.

Methods: Data were analyzed from the "Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation" (RAF-study), a prospective, multicenter, international study including only patients with acute stroke and atrial fibrillation. Patients were followed up for 90 days. Disability was measured by the modified Rankin Scale (0-2 favorable outcome, 3-6 unfavorable outcome).

Results: Of the 1029 patients enrolled, 561 were women (54.5%) (p < 0.001) and younger (p < 0.001) compared to men. In patients with known atrial fibrillation, women were less likely to receive oral anticoagulants before index stroke (p = 0.026) and were less likely to receive anticoagulants after stroke (71.3% versus 78.4%, p = 0.01). There was no observed sex difference regarding the time of starting anticoagulant therapy between the two groups (6.4 ± 11.7 days for men versus 6.5 ± 12.4 days for women, p = 0.902). Men presented with more severe strokes at onset (mean NIHSS 9.2 ± 6.9 versus 8.1 ± 7.5, p < 0.001). Within 90 days, 46 (8.2%) recurrent ischemic events (stroke/TIA/systemic embolism) and 19 (3.4%) symptomatic cerebral bleedings were found in women compared to 30 (6.4%) and 18 (3.8%) in men (p = 0.28 and p = 0.74). At 90 days, 57.7% of women were disabled or deceased, compared to 41.1% of the men (p < 0.001). Multivariate analysis did not confirm this significance.

Conclusions: Women with atrial fibrillation were less likely to receive oral anticoagulants prior to and after stroke compared to men with atrial fibrillation, and when stroke occurred, regardless of the fact that in our study women were younger and with less severe stroke, outcomes did not differ between the sexes.

Keywords: Sex differences; anticoagulation therapy; atrial fibrillation; ischemic stroke; secondary prevention; stroke outcome.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: M Paciaroni has received honoraria as a member of the speaker bureaus of Sanofi-Aventis, Boehringer Ingelheim, Bayer and Pfizer. G Agnelli has received honoraria as a member of the speaker bureaus of Boehringer Ingelheim and Bayer. C Becattini has received honoraria as a member of the speaker bureaus of Bristol Meyer Squibb and Bayer P Michel has received a Research Grant from the Swiss National Science Foundation and Swiss Heart Foundation; he has also received speaker fees from Bayer, Boehringer Ingelheim, Covidien, St. Jude Medical as well as received honoraria for an advisory relationship from Pierre-Fabre, Bayer, Bristol Meyer Squibb, Amgen, and Boehringer Ingelheim. J Putaala has received honoraria for lectures related to atrial fibrillation and anticoagulants for Orion Pharma, Bristol Meyer Squibb, Pfizer, Bayer, and Boehringer Ingelheim. T Tatlisumak received honoraria as consultant or advisory relationship by Lundbeck and Boehringer Ingelheim. G Tsivgoulis had research support by European Regional Development Fund, Project St. Anne's University Hospital, Brno, International Clinical Research Center (FNUSA-ICRC) (No. CZ.1.05/1.1.00/02.0123). D Toni has received honoraria as a member of speaker bureaus and as advisory board member for Boehringer Ingelheim and Bayer. The other authors report no conflicts.

References

    1. Gladstone DJ, Bui E, Fang J, et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 2009; 40: 235–240. - PubMed
    1. Saposnik G, Gladstone D, Raptis R, et al. Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke 2013; 44: 99–104. - PubMed
    1. Hart RG, Pearce LA, Aguilar MI. Metaanalysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857–867. - PubMed
    1. Bushnell C, McCullough L. Stroke prevention in women: synopsis of the 2014 American Heart Association/American Stroke Association Guideline. Ann Intern Med 2014; 160: 853–857. - PMC - PubMed
    1. Cove CL, Albert CM, Andreotti F, et al. Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost 2014; 111.3: 385–391. - PubMed